Evidence reviewed: 8 November 2026. Bipolar disorder is a mental-health condition marked by episodes of mania or hypomania and, in many patients, episodes of depression. It is not simply rapid mood changes throughout an ordinary day. Treatment differs by episode type: medicines helpful for acute mania are not necessarily effective for bipolar depression, and antidepressant monotherapy is not recommended for bipolar I depression. The CANMAT/ISBD guidance and more recent clinical updates emphasize accurate diagnosis, appropriate mood-stabilizing therapy, safety monitoring and relapse prevention [1–3].
Bipolar I, bipolar II and other presentations
| Diagnosis | Defining pattern | Clinical significance |
|---|---|---|
| Bipolar I disorder | At least one manic episode; depressive episodes are common but not required for the diagnosis. | Mania can cause severe impairment, psychosis or hospitalization. |
| Bipolar II disorder | At least one hypomanic episode and at least one major depressive episode, without a full manic episode. | Depressive morbidity can be substantial despite the absence of full mania. |
| Cyclothymic disorder | Longstanding fluctuations of hypomanic and depressive symptoms below full episode thresholds. | Requires a persistent characteristic pattern and clinical assessment. |
| Other specified bipolar presentations | Clinically important patterns not meeting all standard episode criteria. | Must be distinguished from medical, substance-related and other psychiatric disorders. |
Rapid cycling generally refers to four or more distinct mood episodes within 12 months, with qualifying episode features and separation. It does not mean changing feelings several times per hour. Mixed features can involve depressive and manic symptoms together and may raise safety concerns [1,2].
How to recognize mania
Mania is a distinct period of abnormally elevated, expansive or irritable mood and increased activity or energy, generally lasting at least one week or requiring hospitalization sooner. Symptoms can include:
- Markedly decreased need for sleep while still feeling energetic.
- Talking more quickly, racing thoughts or rapidly shifting ideas.
- Inflated self-confidence or grandiosity.
- Increased goal-directed activity, agitation or distractibility.
- Risky spending, sexual behavior, driving or other high-consequence decisions.
- In severe episodes, delusions, hallucinations or major impairment.
Hypomania has similar types of symptoms but is less severe, lasts at least four consecutive days under common diagnostic criteria and does not cause the marked impairment or psychosis characteristic of mania. If psychosis is present, the episode is manic rather than hypomanic. Ordinary excitement or reduced sleep from a deadline is not sufficient for diagnosis. [1,3]
What does bipolar depression look like?
Bipolar depression may include persistent low mood, loss of pleasure, fatigue, guilt, poor concentration, changes in sleep or appetite, psychomotor changes and suicidal thoughts. It can look very similar to unipolar major depression. Important diagnostic clues include previous periods of decreased need for sleep with unusually high energy, episodic impulsivity, a family history of bipolar disorder or past mood elevation associated with antidepressants [1,2].
These features are clues, not proof. A clinician asks about earlier episodes and possible substance use, thyroid illness, neurological causes or medication effects. Correct identification matters because treating bipolar depression exactly like unipolar depression can cause harm.
When is urgent help needed?
Urgent psychiatric or emergency assessment is needed if there is suicidal intent or a plan, psychosis, extreme agitation, dangerous impulsivity, inability to care for oneself, or prolonged near-total sleep loss with escalating mood and energy. Severe mania may require hospital treatment to protect the individual and others. A person with bipolar disorder is not automatically violent, and safety decisions should be based on actual symptoms and risk, not stigma.
What causes bipolar disorder?
Evidence supports a complex interaction of genetic vulnerability, circadian-rhythm disruption, brain signaling networks, stress and environmental factors. Dopamine, glutamate and other neurotransmitters have been studied, but there is no single proven neurotransmitter deficiency or excess explaining every patient. Sleep deprivation and some substances may trigger episodes in susceptible individuals [1,3].
No brain scan, blood test or mathematical formula can independently diagnose bipolar disorder or predict a person’s manic episode. Clinical course, history from the patient and—when appropriate and consented—informants, plus exclusion of alternative explanations, remain central.
Assessment before choosing treatment
A clinician reviews episode duration, sleep and energy changes, depression, psychosis, substance use, suicide risk, prior treatments, pregnancy potential and comorbidities. Some people benefit from standardized mood scales, but these do not replace a clinical assessment. Physical checks may include weight, blood pressure, cardiometabolic risk, kidney and thyroid function, liver tests and reproductive counseling depending on the intended medicine [1,2].
Acute mania: what works?
The CANMAT/ISBD guideline supports lithium, divalproex and selected second-generation antipsychotics for acute mania, either alone or in appropriate combinations. Examples of antipsychotics used in eligible patients include quetiapine, aripiprazole, risperidone, asenapine, cariprazine and paliperidone; approvals and choice differ by country and situation [1].
| Treatment | Main role | Safety considerations |
|---|---|---|
| Lithium | Acute mania and long-term prevention of mood episodes in selected patients. | Requires serum-level, kidney and thyroid monitoring; dehydration and drug interactions can cause toxicity. |
| Divalproex/valproate | Acute mania in appropriate patients. | Potential liver, blood and reproductive toxicity; major pregnancy-related restrictions. |
| Quetiapine, risperidone or other suitable antipsychotics | Reduce manic symptoms; some are combined with mood stabilizers for severe illness. | Metabolic, movement-related, sedation and cardiovascular adverse effects vary. |
| Short-term sedatives when clinically necessary | May manage severe agitation or sleeplessness during supervised acute care. | Not the central long-term mood-stabilizing treatment; dependence and respiratory risks. |
Severe mania, psychosis or inability to sleep safely may require hospitalization, close monitoring and rapid treatment. A person should not start or combine high-dose prescription agents without a specialist [1–3].
Acute bipolar depression requires a different plan
In bipolar I depression, guideline-supported options include quetiapine, lithium, lamotrigine and lurasidone in selected monotherapy or adjunctive combinations; newer evidence also supports cariprazine and lumateperone in relevant settings [1,3]. These agents have different roles, and lamotrigine must be started slowly, so it is not a rapid rescue medicine for a severely suicidal crisis.
The 2023 CANMAT/ISBD evidence update lists antidepressant monotherapy as not recommended for acute bipolar I depression because of uncertain efficacy and the risk of mood switching or cycle destabilization. An antidepressant may sometimes be considered adjunctively under specialist supervision, but not as the automatic treatment for bipolar depression [1].
The best medicine depends on whether mania, depression or mixed features predominate, past responses, pregnancy potential, metabolic risk and current safety. Do not extrapolate a treatment for unipolar depression to bipolar disorder without checking the diagnosis.
What is the role of lithium in long-term care?
Lithium is a foundational mood stabilizer with evidence for preventing manic and depressive relapse and lowering suicide-related outcomes in some populations. It has a narrow therapeutic index, meaning blood levels can become toxic near therapeutic exposures. Kidney and thyroid tests, lithium levels and medication reviews are essential [1–3].
Possible toxicity features include vomiting, worsening tremor, severe diarrhea, confusion, impaired coordination or drowsiness. Dehydration, acute kidney injury and medications such as NSAIDs, ACE inhibitors and some diuretics may raise levels. Severe toxicity symptoms require emergency assessment; do not take extra lithium to compensate for a missed dose.
Valproate and pregnancy precautions
Valproate can be effective for mania, but fetal exposure is associated with a high risk of major malformations and neurodevelopmental harms. Regulations and prescribing restrictions differ by jurisdiction and may apply to both female and male patients. Pregnancy planning, contraception and safer alternatives should be discussed before prescribing, not after conception [2].
Lithium and other mood stabilizers also require individualized reproductive counseling. Do not abruptly stop mood stabilizers during pregnancy; relapse of severe bipolar illness can itself be dangerous. Decisions should involve maternity and specialist psychiatric care.
Lamotrigine and serious rash risk
Lamotrigine is often used to prevent depressive relapse and in selected bipolar depressive episodes, but requires slow dose escalation because of the risk of potentially serious Stevens–Johnson syndrome/toxic epidermal necrolysis. Risk is higher with excessive starting doses and certain interactions, especially valproate. Any new widespread, blistering or mucosal rash needs urgent medical assessment.
Lamotrigine is not a first-line treatment for acute mania. Its role depends on the patient’s phase of illness and the broader treatment strategy [1].
Antipsychotics: effectiveness and monitoring
Selected second-generation antipsychotics are effective in mania, bipolar depression, maintenance or combinations, depending on the specific drug. Quetiapine has evidence across multiple phases; lurasidone has a particular bipolar depression role; aripiprazole is useful for mania or maintenance but is not a preferred monotherapy for acute bipolar depression under CANMAT/ISBD evidence [1].
Monitor weight, waist size, blood pressure, glucose, lipids, sedation, movement disorders and other medication-specific effects. Some antipsychotics are more likely than others to cause metabolic problems, akathisia or QT-related risks. Off-label interchangeability should not be assumed.
What is maintenance treatment?
Once an acute episode settles, long-term treatment aims to reduce relapse, maintain function and support recovery. Depending on subtype and response, options may include lithium, lamotrigine, quetiapine or other selected medicines. Abrupt discontinuation of an effective regimen can increase recurrence risk, so changes should be planned with the treating clinician [1–3].
Psychological care may include psychoeducation, CBT, family-focused interventions, interpersonal and social rhythm therapy and practical relapse planning. Regular sleep timing, reviewing early warning signs and avoiding recreational stimulants can support—but cannot replace—appropriate medical management.
Sleep and circadian rhythms
Changing sleep patterns can both reflect and exacerbate bipolar episodes. Markedly reduced need for sleep with increased energy is particularly concerning for mania or hypomania, while insomnia during depression often involves exhaustion without feeling rested. Care teams may establish consistent sleep–wake schedules and a personalized response plan for early relapse signs.
Intense sleep deprivation or unsupervised sleep restriction therapy may destabilize mood, so insomnia treatment should be adapted to bipolar illness rather than copied from general advice without assessment.
When depression does not improve
Reassess the current episode, adherence, diagnostic subtype, substance use, sleep, comorbid illnesses and previous treatment before adding medications. Electroconvulsive therapy (ECT) is an evidence-supported option for selected severe, high-risk or treatment-resistant mood episodes, including some cases with psychosis or urgent need for response [1–3]. It requires specialist evaluation and anesthesia, not a routine outpatient shortcut.
Other treatments such as neuromodulation are specialized and evidence varies. Avoid unsupported claims that a single supplement, diet or neurotransmitter “reset” can cure bipolar disorder.
Frequently asked questions
Does bipolar disorder mean hourly mood swings?
No. Diagnostic episodes have defined patterns of mood, energy, duration and impairment.
Can bipolar II include full mania?
No. A full manic episode changes the diagnostic classification toward bipolar I [1].
Is an SSRI alone a recommended treatment for bipolar I depression?
No. CANMAT/ISBD guidelines specifically discourage antidepressant monotherapy [1].
Can lithium be taken without blood tests?
No. Serum levels, renal function, thyroid function and interactions require monitoring.
Can lamotrigine treat sudden mania?
It is not an established acute antimanic medicine and must be titrated slowly.
Is valproate safe in pregnancy?
Valproate carries major fetal risks and requires strict prescribing and reproductive precautions.
Key takeaways
Bipolar disorder requires phase-specific diagnosis and treatment. Mania may require lithium, divalproex or an appropriate antipsychotic; bipolar depression has a different evidence base. Antidepressant monotherapy in bipolar I depression is discouraged. Long-term monitoring, sleep regularity and a relapse plan are essential.
References
- Keramatian K, et al. The CANMAT and ISBD guidelines for the treatment of bipolar disorder: summary and a 2023 update of evidence. Focus (Am Psychiatr Publ). 2023;21:344–353. doi:10.1176/appi.focus.20230009.
- National Institute for Health and Care Excellence. Bipolar disorder: assessment and management (CG185). NICE; accessed 8 Nov 2026.
- Clinical practice guidelines for management of bipolar disorder: 2025 update. Full-text clinical guideline. Accessed 8 Nov 2026.
- National Institute of Mental Health. Bipolar disorder. NIH; accessed 8 Nov 2026.
Medical disclaimer: Educational information only. Bipolar disorder diagnosis and medications require psychiatric evaluation, monitoring and individualized safety planning. Do not start or stop mood stabilizers or antidepressants without professional guidance. Suicidal intent, psychosis, severe mania or inability to remain safe requires emergency care.
Medical & AI Disclaimer
The information provided on Sumathi Publications is for general educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional regarding any medical condition or treatment decision.
We strive to keep our content accurate and up to date; however, some content may be created or assisted using artificial intelligence (AI) and may contain errors or omissions. All information should be independently verified before use. Reliance on any content provided by Pharmacology Mentor is at your own risk.